Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
The AQUA Registry Has Been Approved as a Qualified Clinical Data Registry (QCDR) for the 2024 Reporting Period
For the ninth consecutive year, AUA’s AQUA Registry has been approved, by CMS, as a Qualified Clinical Data Registry (QCDR). For the 2024 reporting year, the AQUA Registry will offer a total of 58 quality measures. This includes 8 Non-QPP, 32 QPP and 16 eCQM (electronic clinical quality) measures. The Registry will also offer 2 quality improvement only measures (QPP113 and CMS130), which cannot be used for 2024 MIPS reporting. The CMS approved measures address conditions such as prostate cancer, benign prostatic hyperplasia (BPH), urinary stones, bladder cancer and urinary incontinence.
Additionally, for the first time ever, the AQUA Registry will be supporting MVP reporting. For the 2024 performance year, we will be supporting the Focusing on Women’s Health AND the Advancing Cancer Care MVPs. The AUA’s decision to offer MVPs was made in order to align our workflows with CMS’ transition from traditional MIPS to MVP reporting.
Dates to Remember
April 1, 2024 –December 2, 2024
- 2024 MVP registration window.
- To register, sign into the QPP website with your HCQIS Access and Roles Profile (HARP) account. **A HARP account is required to complete registration.**
advertisement
advertisement